FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation. | Immunology;100(2): 170-7, 2000 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.

Kataoka, T; Yamada, A; Bando, M; Honma, T; Mizoue, K; Nagai, K.

Affiliation

Kataoka T; Department of Bioengineering, Tokyo Institute of Technology, Midori-ku, Yokohama, Taisho Pharmaceutical Co. Ltd, Ohmiya-shi, Saitama, Japan.

Immunology ; 100(2): 170-7, 2000 Jun.

Article in En | MEDLINE | ID: mdl-10886392

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Macrolides / Cytotoxicity, Immunologic / Anti-Bacterial Agents Limits: Animals Language: En Journal: Immunology Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Macrolides / Cytotoxicity, Immunologic / Anti-Bacterial Agents Limits: Animals Language: En Journal: Immunology Year: 2000 Document type: Article Affiliation country: Country of publication: